PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

200 KN PharmaChain certified operations globally: Toronto joins the ranks as fully pharma certified branch

  • Worldwide network of certified locations constantly growing
  • Ensuring globally standardised processes at every compliance level
  • Driving value for pharma & healthcare customers along the entire supply chain

Toronto / CA, February 4, 2019 – The Kuehne + Nagel branch in Toronto, Canada, recently obtained KN PharmaChain seafreight certification, being the 200th certificate globally. Kuehne + Nagel customers in Ontario can now benefit from certified capabilities along the entire supply chain: KN PharmaChain certification ensures training, compliance and the highest quality standards for cold and temperature-controlled multimodal transportation and warehousing services.

“The ongoing trend in the pharma & healthcare industry towards stricter regulations on patient safety as well as strong market competition calls upon innovative logistics solutions. With now 200 certified operations, KN PharmaChain offers our customers integrated, technology enabledand reliable end-to-end logistics solutions covering the highest quality requirements across the globe. It is part of our strategy to provide highly specialised industry-specific solutions reflecting our customers’ needs,” says Dr. Detlef Trefzger, CEO of Kuehne + Nagel International AG.

The certification process is a core element of the KN PharmaChain solution to ensure standardised services across all locations and to guarantee the integrity of the products entrusted to Kuehne + Nagel at any time. The applied GxP standard is based on specific criteria of the Kuehne + Nagel Management System which has been audited and is continuously validated by pharma auditors.

“We are proud to be part of the KN PharmaChain family. Our pharma & healthcare customers can now benefit from superior compliance and enhanced reliability based on proven local expertise and a strong global network,“ says Jamie Wood, National Manager Kuehne + Nagel Canada.

The global KN PharmaChain network includes 600,000 sqm of industry dedicated warehousing space, local teams of specially trained operators and will exceed 200 certified operations by end of the month.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026